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the association between 
accelerometer-assessed physical 
activity and respiratory function 
in older adults differs between 
smokers and non-smokers
Mohamed Amine Benadjaoud1, Mehdi Menai2, Vincent t. van Hees  3, Vadim Zipunnikov4, 
Jean-philippe Regnaux  5, Mika Kivimäki  6, Archana singh-Manoux  2,6 & séverine sabia  2,6
the association between physical activity and lung function is thought to depend on smoking history 
but most previous research uses self-reported measures of physical activity. this cross-sectional study 
investigates whether the association between accelerometer-derived physical activity and lung function 
in older adults differs by smoking history. The sample comprised 3063 participants (age = 60–83 
years) who wore an accelerometer during 9 days and undertook respiratory function tests. Forced 
vital capacity (FVC) was associated with moderate-to-vigorous physical activity (MVPA; acceleration 
≥0.1 g (gravity)) in smokers but not in never smokers: FVC differences for 10 min increase in MVPA 
were 58.6 (95% Confidence interval: 21.1, 96.1), 27.8 (4.9, 50.7), 16.6 (7.9, 25.4), 2.8 (−5.2, 10.7) ml in 
current, recent ex-, long-term ex-, and never-smokers, respectively. A similar trend was observed for 
forced expiratory volume in 1 second. Functional data analysis, a threshold-free approach using the 
entire accelerometry distribution, showed an association between physical activity and lung function 
in all smoking groups, with stronger association in current and recent ex-smokers than in long-term 
ex- and never-smokers; the associations were evident in never smokers only at activity levels above the 
conventional 0.1 g MVPA threshold. These findings suggest that the association between lung function 
and physical activity in older adults is more pronounced in smokers than non-smokers.
Poor lung function, characterized by low forced expiratory volume in 1 second (FEV1) and low forced vital capac-
ity (FVC), is associated with an increased risk of death1,2 and chronic conditions, such as lung cancer3 and cardi-
ovascular diseases.4,5 Lung capacity is largely determined by endogenous factors such as age, sex, and body size 
and early life exposures6,7. However, there is growing interest in modifiable risk factors for poor lung function and 
so far only the role of smoking is widely recognized8. The beneficial impact of physical activity on progression 
of chronic obstructive pulmonary disease (COPD) or asthma9,10 has led researchers to assess the role of physical 
activity11–18 and sedentary behavior14,19 as determinants of poor lung function in the general population. The 
results from these studies suggest that the association of physical activity with lung function might depend on 
smoking history11–13,15,17,18 such that physical activity potentially mitigates the adverse impact of smoking on lung 
function in smokers, possibly via anti-inflammatory and vascular mechanisms20.
Most studies on the association between physical activity and lung function rely on self-reported physical 
activity data which are prone to reporting bias. Physical activity assessed objectively by accelerometers is more 
strongly associated with health outcomes21–23. Typically, these studies categorize the duration of physical activities 
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at different intensities (from sedentary behaviour to moderate-and-vigorous physical activity, MVPA) although this 
method represents important loss of information as the physical activity scale is a continuum. To address this issue, 
functional data analysis is useful in order to model the entire distribution of intensities of accelerometer data24–26.
The present study aims to examine whether the cross-sectional association between accelerometer-assessed 
physical activity and lung function differs by smoking history in a large population-based study of older adults 
aged 60 to 83 years. To address some of the limitations in current evidence, we use (1) usual categories of activity 
intensities and indicators of lung function, FEV1 and FVC, and (2) functional data analysis27 to identify activity 
intensity ranges associated with performance on spirometry test.
Methods
study population. Data are drawn from the Whitehall II cohort study that was established in 1985/88 on 
10308 British civil servants (67% men) aged 35–55 years28. The study design consists of a clinical examination 
every 4–5 years since inclusion. Accelerometer measurement was added to the study at the 2012/13 wave of data 
collection (age range = 60–83 years) for participants seen at the central London clinic and for those living in the 
South-Eastern regions of England who had their clinical assessment at home.
Participants gave informed, written consent to participate, and the University College London Hospital 
Committee on the Ethics of Human Research approved the study, reference number 85/0938. All experiments 
were performed in accordance with relevant guidelines and regulations.
physical activity. During the 2012/13 clinical examination, participants were asked to wear a validated29 
triaxial accelerometer (GENEActiv; Activinsights Ltd, Kimbolton, Cambs, UK) on their non-dominant wrist 
for 9 consecutive, 24-hour, days. The data processing has been described elsewhere23. In brief, the accelerometer 
sampled data at 85.7 Hz rate, acceleration was expressed relative to gravity (g units; 1 g = 9.81 m.s−2)30, averaged 
over 5-second epochs31–33, and corrected for calibration error34.
Accelerometer data were processed in R using the GGIR package version 1.2–11 (https://cran.r-project.org/
src/contrib/Archive/GGIR/). Sleep periods were detected using a validated algorithm aided by a sleep log35. Data 
from the first waking up (day 2) to waking up on the day before last day (day 8) were used, corresponding to 7 
full days. Only waking periods were retained in the analysis, that is periods between waking and sleep onset (as 
opposed to the night period). Participants were included in the analysis if they had valid data, defined as daily 
wear time ≥2/3 of waking hours, for at least 2 weekdays and 2 week-end days. In those with valid data, nonwear 
time was corrected for using a previously reported algorithm30,33,36.
In order for the activity undertaken to be classified as MVPA, mean acceleration over 5s-epoch needed to be 
≥0.10g, between 0.03g and 0.10g for light activity, and <0.03g for sedentary behavior21,23,32,37. The daily time in 
different activity level was calculated as the mean of measures over 7 days. For participants with <7 valid days 
(N = 117), data from weekend and week-days were weighted to represent a 7-day week21–23.
Lung function. Lung function was measured at the clinical examination in 2012/13 without inhalation of 
bronchodilators using a portable flow spirometer (ndd Easy on-PC Spirometer, Zurich, Switzerland) adminis-
tered by a trained nurse. Participants with health contraindications were not allowed to perform the lung function 
tests (details in Supplementary Methods 1). Several parameters were recorded: FEV1, peak expiratory flow, the 
25th, 50th, and 75th percentile forced expiratory flow, and FVC. FVC measures the volume of air that can forcibly 
be blown out after full inspiration, measured in milliliters. FEV1 measures the volume of air expelled in the first 
second during the FVC maneuver, again measured in milliliters38. Among the 5 attempted tests, we retained the 
one with the largest FEV1.
smoking history. Smoking status was assessed by questionnaire every 4–5 years since inclusion. Participants 
were classified based on their smoking history in 2012/13: current smokers, recent ex-smokers (smoking cessa-
tion within 10 years), long-term ex-smokers (smoking cessation more than 10 years before 2012/13) and never 
smokers.
Covariates. Height and weight were assessed by a trained nurse during the clinical examination. Height was 
measured in bare feet to the nearest millimetre using a stadiometer, while the participant stood completely erect 
with the head in the Frankfort plane. Weight was measured in underwear to the nearest 0.1 kg using an electronic 
Soehnle scale with a digital readout (Leifheit AS, Nassau, Germany). Sociodemographic variables were assessed by 
questionnaire and included age, sex, ethnicity (Caucasians, non-Caucasians), marital status (married/cohabiting, 
other), education (5-level variable) and occupational position at age 50 years (high, intermediate or low, represent-
ing income and status at work). Health behaviours were assessed by questionnaire and included alcohol consump-
tion (number of alcoholic drinks consumed in the last seven days, converted to units of alcohol consumed in a 
week and categorized as “no/occasional alcohol consumption”, “moderate alcohol consumption” (1–14 units/week 
in women, 1–21 units/week in men), and “heavy alcohol consumption” (≥14 units in women, ≥21 units in men)), 
and frequency of fruit and vegetables consumption. Among current and recent ex-smokers, the daily number of 
cigarettes smoked was self-reported. Respiratory diseases, including COPD and asthma, were identified using link-
age to national hospital records over the follow-up (1985–2013) and self-reported information on long-standing 
illness in 2012/13. The number of chronic diseases was estimated based on records of coronary heart disease, stroke, 
cancer, depression, diabetes, arthritis, Parkinson’s disease, and dementia identified using linkage to national hospi-
tal records and self-reported information on long-standing illness over the follow-up (1985 to 2013).
statistical analyses. Two sets of analyses were conducted, described below. For all analyses, the significance 
level was 0.05 and all tests were two-sided.
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Association of time spent in activity levels with FEV1 and FVC. We first assessed the association between physical 
activity and lung function in the total study population using linear regressions adjusted for age, sex, ethnicity, 
height, weight, smoking status, time spent in physical activity level under consideration, and waking duration 
(corresponding to the total time spent in sedentary, light and moderate-to-vigorous activities), and then addi-
tionally for socio-demographic and behavioural factors, respiratory disease and the number of chronic diseases. 
Adjustment for height and weight was preferred to adjustment for body mass index as the model fit was better for 
the former (Δ Akaike Information Criteria = 489 for FEV1 and 735 for FVC). Then, to assess whether the asso-
ciation differs by smoking history, we included interaction terms between time spent in activity level under con-
sideration and smoking history (see equation in Supplementary Methods 2). No interactions were found between 
other covariates and smoking history (all p for interaction >0.22) leading us to not include interactions terms 
with other covariates in the model. In order to assess whether the associations observed were driven by presence 
of respiratory diseases, analyses were repeated excluding participants with respiratory disease.
Association between accelerometry distribution and expired air volume curve using functional data analysis. For 
each participant indexed by i, the distribution density function of the 5s-epoch acceleration intensities of the 
waking periods during the observation, designed by fi, was determined using a kernel density estimation39 with a 
Gaussian kernel and a plug-in bandwidth selector method40 implemented in the package “ks” of the R software 
(version 3.5.1 The R Foundation for Statistical Computing http://www.r-project.org/). As acceleration data are 
skewed, the transformation log(1 + acceleration) was applied prior to the kernel smoothing. The complete diurnal 
activity distribution for this subject was then represented by a single function = ×A x T f x( ) ( )i i i  where Ti repre-
sents the daily waking time and x is the magnitude of acceleration variable which takes its values over the range 
of the recorded data measured on g units (see interpretation in Supplementary Methods 3).
For each participant, the flow-volume curve noted F, was reconstituted using the peak expiratory flow, the 25th, 
50th, and 75th percentile forced expiratory flow, and FVC using penalized spline regression. The expired air vol-
ume curve was then deduced as the solution of the autonomous differential equation =y t F y t( ) ( ( ))d
dt
 with the 
condition =y second FEV(1 ) 1 (see interpretation in Supplementary Methods 4). The volume-time function y(t) 
expresses the volume of air exhaled as a function of time (second).
The association between accelerometry distribution, Ai(x), and expired air volume-time function y(t) was 
assessed using a function-on-function regression adjusted for covariates and expressed using regression coeffi-
cient surfaces (see equation in Supplementary Methods 5). This approach allows the identification of the range 
of accelerometry associated with the air volume expired at specific times of the spirometry test. Due to the com-
plexity of the method, the number of covariates included was limited to age, sex, ethnicity, height, weight, respira-
tory disease, and number of chronic diseases6,7. The function-on-function regression was undertaken using the 
REFUND package in R (https://cran.r-project.org/web/packages/refund/refund.pdf). This method allowed us to 
identify accelerometry intensity threshold above which physical activity is associated with better lung function 
in each smoking history group. Then the association of time spent above this threshold with FEV1 and FVC was 
estimated (see details in Supplementary Methods 6).
Results
Among the 4880 participants to whom the accelerometer assessment was proposed, 388 did not consent, 210 had 
contraindications, 15 had their accelerometer lost in the post, 314 did not have valid accelerometer data, and 890 
did not have all data points from the spirometry test to rebuild their volume-time curve (flow chart in Fig. 1). 
Compared to participants not included in the analysis (N = 1817), the analytic sample (N = 3063) did not differ 
by age (69.2 (standard deviation (SD)=5.6) vs. 69.0 y (SD=5.6), P=0.20), but was composed of more men (73.9% 
vs. 65.3%, P < 0.0001) and fewer participants from the lowest occupational position (11.0% vs. 12.4%, P = 0.03). 
Among the 3,063 participants included in the analysis, 2,946 (96.2%) had valid accelerometer data for 7 days, 76 
(2.5%) for 6 days, and 41 (1.3%) for 4–5 days. In total missing data were replaced for 1–2 hours over the full obser-
vational period for 24.5% of the participants, 2–5 hours for 1.0% of the participants, 5–10 hours for 0.6% of the 
participants, and 10–25 hours for 0.1% of the participants. Table 1 presents characteristics of the study population.
In models adjusted for age, sex, ethnicity, height and weight, compared to never smokers, current, recent, 
and long-term ex-smokers had respectively 360.0 (95%CI = 254.1, 466.0), 305.6 (95%CI = 221.8, 387.5) and 
55.0 (18.5, 91.5) ml lower FEV1, and 278.6 (95%CI = 157.2, 400.0), 238.3 (95%CI = 143.3, 333.2) and 47.6 
(95%CI = 5.7, 89.4) ml lower FVC (data not tabulated).
Association of time spent in activity levels with FEV1 and FVC. In analyses adjusted for age, sex, 
ethnicity, height, weight, and waking duration, the interaction terms between time spent in MVPA and smoking 
history (entered as an ordinal variable) were significant for both FEV1 (p = 0.0002) and FVC (p < 0.0001). In 
fully adjusted analyses, 10 minutes greater MVPA was associated with 58.6 (95%CI = 21.1, 96.1) ml higher in 
FVC in current smokers, 27.8 (95%CI = 4.9, 50.7) ml increase in recent ex-smokers, 16.6 (95%CI = 7.9, 25.4) 
ml in long-term ex-smokers, and only 2.8 (95%CI = −5.2, 10.7) ml in never smokers (Table 2). Similarly, the 
association between sedentary time and lung function was evident in current but not in never smokers (p for 
interaction = 0.02 for FEV1 and 0.03 for FVC). There was no evidence of an association of FEV1 and FVC with 
light physical activity in all smoking groups, the p for interaction did not reach significance for FEV1 (p = 0.06) 
and FVC (p = 0.09). After exclusion of participants with respiratory disease, the association of MVPA with both 
FEV1 and FVC was slightly attenuated whereas the association with sedentary time remained only for FVC among 
current smokers (Supplementary Table 1).
Association between diurnal accelerometry distribution and expired air-volume curve using 
functional data analysis. The accelerometry distribution Ai(x) and the expired air volume-time curve yi(t) 
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are plotted in Fig. 2; current smokers spent more time in the lowest accelerometry range. Differences in spirome-
try test were evident all along the distribution, with never and long-term ex-smokers having better lung function 
profiles. The plot of the expired air volume-time curve are displayed in the top row of Supplementary Fig. 1 for all 
the participants, with median functions separately in men and women (left panel), age quartiles (middle panel) 
and in Caucasians and non-Caucasians (right panel). The regression coefficients for the association of sex, age 
(per 1 year) and ethnicity with the expired air volume are shown with their 95% confidence interval in the bot-
tom row. These results show the association of these covariates along the continuum of spirometry performance 
Figure 1. Flow Chart of the Study. * valid data defined as daily wear time ≥2/3 of waking hours, for at least 2 
weekdays and 2 week-end days.
All (n = 3063)
Smoking history
p
Current smokers 
(n = 86)
Recent 
ex-smokers 
(n=146)
Long-term 
ex-smokers 
(n = 1251)
Never smokers 
(n = 1580)
N = 3063 N = 86 N = 146 N = 1251 N = 1580
Age (years), M(SD) 69.2 (5.6) 67.3 (4.8) 68.2 (5.2) 69.7 (5.6) 69.0 (5.7) <0.001
Men (%) 73.9 69.8 75.3 77.9 70.8 <0.001
Caucasian (%) 93.4 93.0 94.5 95.5 91.7 0.003
Height (cm), M(SD) 170.8 (9.1) 170.3 (8.4) 170.7 (8.6) 171.3 (8.7) 170.5 (9.4) 0.08
Weight (kg), M(SD) 77.7 (14.1) 78.4 (16.2) 80.0 (14.5) 79.0 (14.3) 76.4 (13.8) <0.001
High occupational position at age 50y (%) 45.5 27.9 39.7 45.1 47.3 0.002
Higher education than university (%) 31.4 19.8 21.9 27.3 36.1 <0.001
Married/cohabitating (%) 75.7 58.1 69.9 79.0 74.7 <0.001
High alcohol consumption (%) 14.4 24.4 25.3 18.6 8.7 <0.001
Daily fruit and vegetable consumption (%) 80.3 54.7 75.9 79.1 83.1 <0.001
Cigarettes smoked (per day), M(SD) 12.9 (7.7) 5.6 (11.1)* <0.001
Respiratory diseases (%) 8.0 7.0 15.1 7.9 7.5 0.01
One or more chronic diseases (%) 46.7 48.8 54.1 51.1 42.5 <0.001
Time spent per day (min), M(SD)
Sedentary behaviour 673.9 (88.1) 698.4 (76.8) 674.4 (105.6) 671.9 (86.1) 674.1 (88.4) 0.03
Light physical activity 240.5 (58.1) 220.8 (52.9) 237.3 (70.8) 240.8 (56.6) 241.7 (58.2) 0.009
MVPA 69.3 (36.7) 58.0 (31.3) 69.2 (41.2) 70.1 (37.0) 69.3 (36.2) 0.05
FVC (ml), M(SD) 3639.4 (925.4) 3407.9 (989.9) 3462.4 (973.9) 3667.2 (887.6) 3646.5 (943.7) 0.008
FEV1 (ml), M(SD) 2790.5 (742.2) 2501.1 (767.4) 2565.9 (816.0) 2809.5 (713.1) 2811.8 (750.2) <0.001
Table 1. Characteristics of the study population. Abbreviations: FEV1, Forced Expiratory Volume in 1 sec; FVC, 
Forced Vital Capacity; MVPA, Moderate to vigorous physical activity. p: Chi-Square or Anova. *Number of 
cigarettes smoked before they stopped smoking.
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and not confined to 1 second (FEV1) or at 5 seconds (FVC) as used in the classical multivariate approach. The 
direction and strength of association using functional coefficients are consistent with results from the multivar-
iate regression for FEV1 (beta for women vs men = −474.7 (−527.8, −421.5) ml) and FVC (beta for women vs 
men = −576.3 (−638.0, −514.7) ml) at 1 second and 5 second respectively.
Results from function-on-function regression model are presented in Fig. 3, showing the significant coef-
ficient surfaces in each smoking history group and their slices at times 0.5, 1 (FEV1), 3, and 5 (FVC) seconds. 
The acceleration levels above which association with spirometry measure was evident were higher in a graded 
fashion from current to never-smoker groups. A positive (protective) association between physical activity and 
FVC (time = 5 seconds) was observed for accelerometry values above 0.054g among current smokers, 0.094g 
among recent ex-smokers, 0.074g among long-term ex-smokers and 0.161g among never smokers (Table 3). 
More time spent in activity intensities above these smoking-specific accelerometry thresholds was associated 
with higher FVC, with stronger associations observed in current and recent ex-smokers (Table 3). A similar trend 
was observed for FEV1. Results in the lower range of accelerometry were less consistent but overall lower lung 
function was observed for more time spent at lower accelerometry level among current smokers (<0.03g).
Discussion
Principal findings. This study of 3063 adults aged 60 to 83 years presents three key findings. First, results 
based on conventional categorization of physical activity showed that the association between MVPA and lung 
function is dependent on smoking history, with associations being evident only in current and ex-smokers. 
Second, function-on-function regression, which takes the continuum of measurement into account, shows an 
association between physical activity and lung function, both FEV1 and FVC, in all smoking groups but only at 
very high levels of physical activity in never smokers. Third, lung function is less consistently associated with time 
spent in sedentary activity, the association being only evident for FVC among current smokers.
Comparison with others studies. Longitudinal studies based on self-reported physical activity measures 
have suggested that physical activity in midlife and early old age is associated with slower decline in lung func-
tion16,17,41. In studies that have investigated the modifying role of smoking, physical activity was found to be 
associated with higher FEV1 and FVC12, slower decline in lung function13 and lower risk of incident chronic 
obstructive pulmonary disease11, only in current or ever-smokers. One study using accelerometer-assessed 
Total population
Smoking history
Current smokers Recent ex-smokers Long-term ex-smokers Never smokers
β* [95% CI] β [95% CI] β [95% CI] β [95% CI] β [95% CI]
FVC (ml)
  Model 1†
    For 10 min increase per day
       Sedentary behaviour −2.5 [−5.0, −0.0] −19.2 [−34.7, −3.7] −6.1 [−15.0, 2.8] −2.8 [−6.6, 0.9] −1.2 [−4.4, 2.1]
       Light activity 0.8 [−2.7, 4.4] 14.1 [−8.4, 36.6] 0.4 [−13.0, 13.7] 3.6 [−2.0, 9.2] −1.7 [−6.6, 3.1]
       MVPA 11.9 [5.9, 17.9] 60.3 [22.3, 98.2] 33.8 [11.1, 56.6] 16.6 [7.8, 25.4] 3.6 [−4.4, 11.6]
  Model 2‡
    For 10 min increase per day
       Sedentary behaviour −2.6 [−5.1, −0.1] −19.4 [−34.7, −4.1] −4.0 [−12.9, 4.9] −3.3 [−7.1, −0.5] −1.1 [−4.4, 2.1]
       Light activity 1.2 [−2.4, 4.8] 14.0 [−8.3, 36.3] −0.4 [−13.6, 12.8] 4.1 [−1.4, 9.6] −1.5 [−6.3, 3.4]
       MVPA 11.4 [5.4, 17.4] 58.6 [21.1, 96.1] 27.8 [4.9, 50.7] 16.6 [7.9, 25.4] 2.8 [−5.2, 10.7]
FEV1 (ml)
  Model 1†
    For 10 min increase per day
       Sedentary behaviour −1.0 [−3.2, 1.2] −13.2 [−26.7, 0.4] −6.5 [−14.2, 1.3] −1.0 [−4.6, 2.3] 0.2 [−2.7, 3.0]
       Light activity −0.7 [−3.8, 2.5] 9.4 [−10.2, 29.1] 3.3 [−8.3, 15.0] 0.9 [−4.0, 5.7] −2.7 [−7.0, 1.5]
       MVPA 7.7 [2.4, 12.9] 32.6 [−0.5, 65.7] 31.5 [11.7, 51.4] 11.8 [4.1, 19.4] 0.5 [−6.5, 7.5]
  Model 2‡
    For 10 min increase per day
       Sedentary behaviour −1.1 [−3.3, 1.0] −13.8 [−26.9, −0.7] −4.8 [−12.4, 2.8] −1.6 [−4.8, 1.6] 0.2 [−2.5, 3.0]
       Light activity −0.2 [−3.2, 2.9] 8.6 [−10.5, 27.6] 3.8 [−7.6, 15.1] 1.6 [−3.1, 6.3] −2.5 [−6.6, 1.6]
       MVPA 7.5 [2.3, 12.6] 31.2 [−0.9, 63.3] 27.6 [7.9, 47.2] 12.3 [4.8, 19.8] −0.2 [−7.0, 6.6]
Table 2. Association between physical activity and respiratory function. Abbreviations: CI, confidence interval; 
FEV1, Forced Expiratory Volume in 1 sec; FVC, Forced Vital Capacity; MVPA, Moderate to vigorous physical 
activity. *Additional adjustment for smoking history. †Model 1: adjusted for age, sex, ethnicity, height, weight, 
and waking duration. ‡Model 2: Model 1 additionally adjusted for occupational position at age 50y, education, 
marital status, alcohol consumption, fruit and vegetable consumption, respiratory disease, and number of 
chronic diseases. Additionally adjusted for number of cigarettes smoked per day among the current and recent 
ex-smokers (corresponding to cigarettes smoked before they quitted smoking) groups.
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physical activity among 341 adults assessed the cross-sectional association of MVPA with lung function, without 
accounting for time spent in sedentary behavior and light activities, and also reported the association with MVPA 
to be evident only in smokers15. Our study using objective physical activity data on a large sample of older adults 
adds to the previous findings by showing that the activity intensity threshold at which there is an association 
between physical activity and lung function depends on smoking history. The association between spirometry 
measure and physical activity was evident starting from activities in the higher range of light intensities (accel-
eration ≥0.06g) in smokers, from physical activities of moderate-to-vigorous intensities (acceleration ≥0.10g) 
in ex-smokers and from even more intense MVPA in never smokers. The associations were found all along the 
spirometry measure, including both FEV1 and FVC. Several mechanisms could underlie the association between 
physical activity and lung function. They may involve the anti-inflammatory and vascular benefits of physical 
activity20. These mechanisms might play a more pronounced role among smokers by compensating for the delete-
rious effect of smoking on the lung13,20. As the study is cross-sectional, the observed association could also reflect 
the inability of those with poor lung function to perform physical activity at higher intensity and this would be 
more pronounced among smokers who might carry multiple health conditions affecting their ability to undertake 
more intense physical activity42.
Sedentary behaviour is thought to be deleterious for health43. However, it is unclear whether time spent seden-
tary is important because of the adverse effects of inactivity or because it reduces the time available for activities 
at more intense levels43, given that a day is constrained naturally to 24 hours. Few studies have assessed the impact 
of sedentary behaviour on lung function and no robust association has been reported14,19. In the present study, an 
association between spirometry measure and sedentary time was found only in current smokers. In other smok-
ing groups, the association was small and inconsistent across the various analytic approaches. Both the classical 
and functional approaches accounted for the diurnal duration constraint so that increase in sedentary time corre-
sponds to decrease in active time. Our findings of an association between sedentary behaviour and lung function 
in current smokers could reflect an aggravating effect of sedentary behaviour on lung function in smokers or the 
likelihood of smokers with poor lung function to be more sedentary.
Figure 2. Accelerometry distribution during waking time and volume of air expired over time as a function 
of smoking status. Grey curves represent individual daily accelerometry distribution over waking time (left 
panel, number of 5s-epoch over diurnal time) and expired air volume over the time of the spirometry test (right 
panel). Colored curves represent the median curves among the different smoking history groups.
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strengths and limitations. Strengths of this study include the large sample size, use of accelerometer- 
assessed physical activity, and functional data analysis approach that is free from laboratory-based thresholds 
definition of sedentary, light and moderate-to-vigorous activity and accounts for the entire spirometry and 
diurnal activity intensity distribution. We were able to identify intensities at which physical activity was asso-
ciated with respiratory function in groups defined by smoking history. The limitations of this study include its 
cross-sectional design, although sensitivity analysis excluding COPD and asthma cases were conducted to assess 
whether the association observed between physical activity and spirometry measure was not driven by difficul-
ties in undertaking physical activity among those with respiratory diseases, and the results were broadly similar. 
Further longitudinal studies are needed to assess the direction of the association between physical activity and 
respiratory function. Second, although the number of current smokers was small, the trend observed across the 
smoking groups suggested that the results in smokers were not likely to be by chance. However, future studies 
are needed to confirm effect size in this group. Finally, although wrist-mounted accelerometer are not designed 
to distinguish between sitting and inactive standing position, the 0.03 g threshold we used has been reported to 
accurately separate sedentary behaviours from common motion-based light-intensity activities37.
Figure 3. Coefficient surfaces representing the association between accelerometry distribution (X axis) and 
volume of expired air over time (Y axis) and their slices at times 0.5, 1 (FEV1), 3, and 5 (FEC) seconds by 
smoking history*. *Coefficient surfaces and their slices at times 0.5, 1 (FEV1), 3, and 5 (FVC) seconds (only 
significant coefficients at P < 0.05 are shown), from a function-to-function regression model to assess the 
association between expired air volume-time curve (Y axis) and accelerometry distribution (X axis) adjusted 
for age, sex, ethnicity, height, weight, respiratory disease, number of chronic diseases, and accelerometry 
distribution by smoking history groups. Positive values indicate that more time spent in a given accelerometry 
range is associated with higher air expired volume over the spirometry time scale whereas negative values 
indicate that more time spent in a given accelerometry range is associated with lower air expired volume over 
the spirometry time scale.
Current smokers Recent ex-smokers Long-term ex-smokers Never smokers
FVC (ml)
Accelerometry threshold 0.054 0.094 0.074 0.161
ΔFVC  *[95% CI] for 10 min increase per day in 
activity intensity above the threshold 34.7 [23.3, 49.1] 36.5 [29.4, 47.4] 15.1 [13.1, 22.4] 13.2 [7.5, 20.1]
FEV1 (ml)
Accelerometry threshold 0.060 0.093 0.122 0.150
ΔFEV1 *[95% CI] for 10 min increase per day in 
activity intensity above the threshold 21.5 [15.1, 28.7] 30.2 [23.7, 35.9] 11.0 [8.5, 13.7] 8.9 [5.3, 12.8]
Table 3. Association between physical activity and respiratory function using threshold for benefits identified 
using functional data analysis. Abbreviations: CI, confidence interval; FEV1, Forced Expiratory Volume in 1 sec; 
FVC, Forced Vital Capacity; CI, confidence interval. *Estimated change from a function-to-function regression 
model adjusted for age, sex, ethnicity, height, weight, respiratory disease, and number of chronic diseases.
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Conclusion
This study on older adults showed an association between physical activity and better lung function, particularly 
in recent ex- and current smokers. Among never smokers, the intensity of physical activity required to create an 
association with lung function was well above that used to define MVPA. These findings suggest that the associ-
ation between physical activity and lung function might have been underestimated in non-smokers in previous 
studies that did not differentiate between intensities of MVPA.
Data Availability
Whitehall II data, protocols, and other metadata are available to the scientific community. Please refer to the 
Whitehall II data sharing policy at https://www.ucl.ac.uk/whitehallII/data-sharing.
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